Category: News

An Update on the Burn Pits Accountability Act of 2019

an-update-on-the-burn-pits-accountability-act-of-2019

Click here to read our statement in support of the legislation. GO2 Foundation for Lung Cancer is pleased to report the recent advancement of the Burn Pits Accountability Act. We strongly support this legislation as a first step to ensure that all those affected by burn pit toxins are accounted […]

New Treatment Approved for Metastatic Small Cell Lung Cancer

new-treatment-approved-for-metastatic-small-cell-lung-cancer

On June 17, 2019, the U.S. Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA) for patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy. Though pembrolizumab is an established treatment option for […]

Early Screening Equals Early Diagnosis

early-screening-equals-early-diagnosis

GO2 Foundation for Lung Cancer’s recently published scientific paper found that lung cancer screening programs can successfully detect lung cancer early with the majority of lung cancers diagnosed at stage 1 or limited stage. Importantly, outcomes at academic and nonacademic sites were compared and the data confirmed that responsible screening […]

Lung Cancer News from the Largest Oncology Meeting

lung-cancer-news-from-the-largest-oncology-meeting

The GO2 Science and Research team just returned from the 2019 American Society of Clinical Oncology (ASCO) meeting. We connect you and your loved ones to the latest research and treatment options by keeping up with the latest advances at meetings like ASCO. While there we saw exciting presentations on […]

Latest Update to Lung-RADS (1.1) is Complete!

latest-update-to-lung-rads-(1.1)-is-complete!

Over the weekend, the long-awaited update of Lung-RADS was published with changes that aim to reduce lung cancer screening false positives by downgrading many category 3 findings to category 2. Lung-RADS (lung imaging reporting and data system) is a quality assurance tool to aid with findings in low-dose CT screenings […]

Patient Voices Were Heard: Preserving Access to Life Saving Drug Therapies!

patient-voices-were-heard:-preserving-access-to-life-saving-drug-therapies!

On May 17, 2019, The Centers for Medicare & Medicaid Services (CMS) released the final Medicare Part D Rule, where they decided to preserve the original Six Protected Classes policy. GO2 Foundation for Lung Cancer (formerly Lung Cancer Alliance and the Bonnie J. Addario Lung Cancer Foundation) advocated to stop the […]

How To Talk To Kids About Dying and Death

how-to-talk-to-kids-about-dying-and-death

An excerpt from Rethink’s new resource: Talking To Kids About Metastatic Breast Cancer written by Child Life Specialist, Morgan Livingstone, edited by Registered Psychotherapist Andrea Warnick, and illustrated Ashley Doyle.  Talking About Dying and Death The other BIG question some kids ask, and parents tend to dread, is: “Are you […]

Research Wins Big

research-wins-big

The GO2 Foundation for Lung Cancer is honored to announce that on May 2 two of our programs received Your Cancer’s Cancer Community (C2) Awards. These awards celebrate “the unsung heroes of cancer care”—individuals and organizations that advance cancer care and work to improve the lives of those living with […]

FDA Approves First-Line Treatment for NSCLC with PD-L1 Biomarker

fda-approves-first-line-treatment-for-nsclc-with-pd-l1-biomarker

On April 11, the U.S. Food and Drug Administration approved pembrolizumab (KEYTRUDA) as a first-line treatment for patients with advanced NSCLC who have a score of 1% or higher on the PD-L1 biomarker test. The approval was based on KEYNOTE-042 trial which demonstrated statistically significant OS improvements for those randomized […]

Priority Focus Renewed on Women’s Health Imperative – House and Senate Leaders Reintroduce Women and Lung Cancer Research and Preventive Services Act of 2019

priority-focus-renewed-on-women’s-health-imperative-–-house-and-senate-leaders-reintroduce-women-and-lung-cancer-research-and-preventive-services-act-of-2019

GO2 Foundation for Lung Cancer hails bipartisan effort to accelerate progress to increase survivorship April 10, 2019 – Today the GO2 Foundation for Lung Cancer praises Senators Marco Rubio (R-FL), Dianne Feinstein (D-CA), Shelley Moore Capito (R-WV), and Joe Manchin (D-WV), and Representatives Brendan Boyle (D-PA), Brian Fitzpatrick (R-PA), Debbie Dingell […]